TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Level of histopathological changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological Complete Response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Trendelenburg sign
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between RNA-Seq and RT-PCR results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adoption (Mentees)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Adoption (Mentors)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Feasibility (Mentees)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Feasibility (Mentors)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Appropriateness (Mentees)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Arm circumference and volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arm mobility measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of thrombotic microangiopathies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of PALB2-related breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of subjects with treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Response measured by the Brief Pain Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Response measured by the Bone Mets Pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety through 30 days post-radiation
Endpoint domain: Adverse events/effects
Primary endpoint: Lawton Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Accuracy of 3D sensor for lymphedema volumetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Health related quality of life (HRQOL) - Patient
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health related quality of life (HRQOL) - Parent
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cmax,ss of DWC202313 and DWC202314
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt,ss of DWC202313 and DWC202314
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants completing study treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ctDNA levels predictive of disease response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthesis retention/survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence and progression of new and pre-existing NCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of NCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom burden of NCD
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Rate of negative in-field biopsy at 12 months (primary setting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of advancement to systemic therapy or radical salvage therapies (primary setting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in urinary function as measured by IPSS questionnaire (primary setting)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in erectile function as measured by IIEF-5 score questionnaire (primary setting)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Whole genome expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory muscle strength (inspiration) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory muscle strength (expiration) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Kessler-10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: KIDSCREEN-10 extended
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Teacher Stress Inventory (TSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of on-task/off-task behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient enrollment assessed by consent rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient trial completion assessed by number of patients who complete study assessments and trial procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient satisfaction assessed by patient feedback questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of postoperative ileus (POI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average change from baseline in viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of viral activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in skin health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Volume of the ear canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width between conductance peaks of tympanometry at 2kHz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Middle ear resonance frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of inadequate dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: corneal endothelium cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal endothelial cell size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal endothelial cell shape
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of embolisation procedure
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Feasibility of open neck vessel ligation
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Number of classes participants attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance to the exercise prescription based on heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of treatment initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of engagement in treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percent days abstinent from alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthodontic patient comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Informed consent form comprehension assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction after the procedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence, severity, and dose-relationship of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Neurofunctional activity specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Abdominal Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Defecation consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MVI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of 18F-JK-PSMA-7 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of laboratory-identified invasive fungal pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in 25-hydroxyvitamin D (25D) and iPTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sensibility of bronchial ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinitis Sicca Symptom Score (RSSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric neutralizing titers of neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Requirement of Oxymetalozine Rescue for Ear Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of transplant and TIPS
Endpoint domain: Mortality/survival
Primary endpoint: Infection related-hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of recurrent urinary tract infections
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of Contact Dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bone Mineral Density (BMD) volumic values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of adherence to lipid-lowering medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breathing route while on pressure support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants who Experience One or More Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants who Experience One or More Treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants who Experience Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: O'Leary/Sant questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pelvic Pain and Urgency/Frequency questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of calculated stent length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of pathological sequelae due to SARS-Cov2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: External anal sphincter muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kessler-10 (K10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of hematoma post-operative
Endpoint domain: Adverse events/effects
Primary endpoint: Re-tear rate at 12 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: The manner of death
Endpoint domain: Mortality/survival
Primary endpoint: Consistency rate between preoperative prediction and postoperative results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falling risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Near Point of Convergence and Positive Fusional Vergence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Severity Index Scale (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Pittsburgh Sleep Quality Index Scale (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: change of retention of versacrylic and CAD/CAM partial denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of chewing efficiency of versacrylic and CAD/CAM partial denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of masticatory performance of versacrylic and CAD/CAM partial denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertigo symptom scale - short form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worry or anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Testing- and intervention-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient exercise adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Timed Up & Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip Strength using a Jamar Hydraulic Hand Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Between group difference in PSP Rating Scale (PSPRS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Between group difference in Unified MSA Rating Scale (UMSARS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axillary status prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax of elinzanetant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-24) of elinzanetant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal effect-site concentration of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in systemic inflammatory response syndrome (SIRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intra-abdominal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in resting pain and movement pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Post-inflammatory hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants With Clinically Significant Changes in 12-lead Electrocardiogram (ECG) Laboratory Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Plasma Concentration Curve From Time Zero to Last Time of Quantifiable Concentration (AUC[0-t]) of GSK3884464 Following Single Dose Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGA score for patients with melasma or acne induced post-inflammatory hyperpigmentation (PIHP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Oral extraintestinal manifestations (EIMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering serum phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endogenous Oxalate Synthesis Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients receiving palbociclib in combination with aromatase inhibitors or fulvestrant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients receiving other cancer treatment regimens
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concentration biomarkers and coagulation assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Modified Tardieu Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of ocular and non-ocular treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of adalimumab
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of Diabetes Retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: Presence of Diabetes Neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of Diabetes Nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Area Under the Curve following first Carbohydrate load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve following second Carbohydrate load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BAT outcome nasal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BAT outcome serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of major adverse cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cannabis-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Surface Microhardness Recovery (%SMHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of brain pulse oximeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orthodontic plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of acute respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Biomarkers levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGLT2i-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: any rehospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to the first COPD acute exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Core competencies in infection control and prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Contrast-to-Noise Ratio (CNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of SSP participants reached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Modified Rankin Scale (mRS) of 0-3
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of FSHR and LHR of the GC on day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of FSHR and LHR of the GC from follicles of size 12 to 14 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of FSHR and LHR of the GC from pre-ovulatory follicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of FSHR and LHR of the GC from follicular fluid during OPU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in wound volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in high frequency heart variability (HF-HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Eye Health Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Biodistribution of 18F-pretomanid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-hour pad weight test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who will need mechanical ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Global aesthetic improvement scale (GAIS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in gene expression signature in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gugging Swallowing Screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of behavioral and psychological symptoms of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of the virtual reality intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Major Depressive Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opiate use at 14 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of ≥3 grade adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Poor postoperative outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of the DOAC Dipstick
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the DOAC Dipstick
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multidimensional Treatment Satisfaction Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status